Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
251.00    0.00 (0.00%)
Bid:
221.00
Ask:
0.00
Spread: 27.00 (12.217%)
Market Cap: £146.42m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Result of AGM

7 Dec 2012 12:02

RNS Number : 0371T
Gleeson(M J)Group PLC
07 December 2012
 

M J Gleeson Group plc

("the Company")

 

M J Gleeson Group plc - AGM Results

 

The Company announces that all the resolutions put to the Annual General Meeting held at 11.00 a.m. today were passed on a show of hands.

 

The following table gives details of the proxy votes lodged with the Company's registrars as at 5 December 2012.

 

Resolution

Total Votes For *(%)

Total Votes Against(%)

Total VotesWithheld

1. To receive and adopt the Accounts for the year ended 30 June 2012 and the Directors' and Auditors' Reports thereon.

20,704,171

(99.99%)

220

(0.01%)

530

2. To re-appoint Ross Ancell as a Director.

20,635,592

(99.67%)

68,988

(0.33%)

0

3. To re-appoint Alan Martin as a Director.

20,696,755

(99.96%)

7,825

(0.04%)

0

4. To re-elect Dermot Gleeson as a Director.

20,510,569

(99.96%)

7,375

(0.04%)

0

5. To re-elect Jolyon Harrison as a Director.

20,694,906

(99.95%)

10,015

(0.05%)

0

6. To re-elect Colin Dearlove as a Director.

20,652,825

(99.75%)

51,755

(0.25%)

0

7. To re-elect Christopher Mills as a Director.

20,635,072

(99.66%)

69,508

(0.34%)

0

8. To re-appoint KPMG Audit Plc as Auditors and to authorise the Directors to determine their remuneration.

20,663,490

(99.80%)

41,431

(0.20%)

0

9. To approve the Directors' Remuneration Report

20,637,567

(99.69%)

65,104

(0.31%)

2,250

10. To authorise the Directors to allot shares in the Company pursuant to Section 551 of the Companies Act 2006.

20,587,813

(99.46%)

111,990

(0.54%)

5,118

11. To disapply pre-emption rights in connection with a rights issue or other allotments up to approximately 5% of the Company's issued share capital.

20,670,633

(99.87%)

27,859

(0.13%)

6,088

12. To authorise the Company to purchase its own shares under Section 701 of the Companies Act 2006.

20,686,318

(99.91%)

17,822

(0.09%)

440

13. To authorise the Company to call General Meetings other than Annual General Meetings on not less than 14 clear days' notice.

20,658,995

(99.78%)

45,145

(0.22%)

440

* Includes discretionary votes

 

Copies of the special business resolutions passed at the Annual General Meeting will shortly be available for inspection via the Financial Services Authority's National Storage Mechanism located at http://www.hemscott.com/nsm.do

 

There were 52,876,487 ordinary shares of 2p each in issue on 7 December 2012.

 

Further information is available from:

 

Alan Martin, Chief Financial Officer 01252 360300

 

7 December 2012

 

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGBKODKBBDDDBK
Date   Source Headline
9th Jun 20262:17 pmRNSDirector/PDMR Shareholding
9th Jun 20267:00 amRNSUpdate on Gleeson Land
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.